- Kevin Sayer, former Dexcom CEO and current Executive Chairman, joins Board of Directors
- Routine Item 5.02 governance appointment filing
- No direct impact on financial results or guidance
Neutral AI Sentiment (+0.5 / 10)
Signal #119831 · SEC 8-K
$GH SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $GH filing catalyst
Why did $GH trigger an AI stock catalyst alert?
$GH triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: +0.5/10). Headline: Guardant Health Appoints Former Dexcom CEO Kevin Sayer to Board. Key points: - Kevin Sayer, former Dexcom CEO and current Executive Chairman, joins Board of Directors - Routine Item 5.02 governance appointment filing - No direct impact on financial results or guidance
How did $GH stock react after the SEC filing?
After the SEC 8-K for $GH, observed market reaction: T0 price $175.00. Past moves do not guarantee future results.
Where can I get real-time $GH SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $GH via Telegram and the VIP Web Terminal from €10/month.